p53, vessel count, and vascular endothelial growth factor expression in human colon cancer

International Journal of Cancer

Volumn 79, Issue 1, 1998, Pages 34-38

  Takahashi, Yutaka ^a   Bucana, Corazon D ^b   Cleary, Karen R ^b   Ellis, Lee M ^b,c  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER SURGERY; COLON CANCER; CORRELATION FUNCTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

ADENOMA; COLONIC NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHOKINES; NEOPLASM METASTASIS; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032548970     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980220)79:1<34::AID-IJC7>3.0.CO;2-X     Document Type: Article

References (28)

1. ASTLER, V. and COLLER, F., the prognostic significance of direct extension of carcinoma of the colon and rectum. Ann. Surg., 139, 846-851 (1954).
2. DAMERON, K.M., VOLPERT, O.V., TAINSKY, M.A. and BOUK, N., Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science, 265, 1502-1504 (1994).
3. ELLIS, L.M., LIU, W. and WILSON, M., Downregulation of vascular endothelial growth factor in human colon carcinoma cell lines by antisense transfection decreases endothelial cell proliferation. Surgery, 120, 871-878 (1996).
4. GASPARINI, G., WEIDNER, N. and BEVILACQUA, P., Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int. J. Cancer, 55, 739-744 (1993).
5. GASPARINI, G., WEIDNER, N., BEVILACQUA, P., MALUTA, S., DALLA PALMA, P., CAFFO, O., BARBARESHI, M., BORACCHI, P., MARUBINI, E. and POZZA, F., Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J. clin. Oncol., 12, 454-466 (1994).
6. GINSBERG, D., MECHTA, F., YANIV, M. and OREN, M., Wild-type p53 can down-modulate the activity of various promoters. Proc. nat. Acad. Sci. (Wash.), 88, 9979-9983 (1991).
7. GREENBLATT, M.S., BENNETT, W.P., HOLLSTEIN, M. and HARRIS, C.C., Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
8. HAMELIN, R., LAURENT-PUIG, P., OLSCHWANG, S., JEGO, N., ASSELAIN, B., REMVIKOS, Y., GIRODET, J., SALMON, R.J. and THOMAS, G., Association of p53 mutations with short survival in colorectal cancer. Gastroenterology, 106, 42-48 (1994).
9. IKEDA, E., ACHEN, M.G., BREIER, G. and RISAU, W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. biol. Chem., 34, 19761-19768 (1995).
10. KASTRINAKIS, W.V., RAMCHURREN, N., RIEGER, K.M., HESS, D.T., LODA, M., STEELE, G. and SUMMERHAYES, I.C., Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression. Oncogene, 11, 647-652 (1995).
11. KIESRR, A., WEICH, H.A., BRANDNER, G., MARME, D. and KOLCH, W., Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor. Oncogene, 9, 963-969 (1994).
12. KOURA, A.N., RADINSKY, R., KITADAI, Y., TAKAHASHI, Y. LIU, W., SINGH, R. and ELLIS, L.M., Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by cell density. Cancer Res., 56, 3891-3894 (1996).
13. KOURA, A.N., VAN GOLEN, K., TSAN, R., RADINSKY, R., PRICE, J.E. and ELLIS, L.M., Regulation of genes associated with angiogenesis, growth, and metastasis by specific point mutations in a murine melanoma cell line. Oncology Rep., 4, 475-479 (1997).
14. LEPELLEY, P., PREUDHOMME, C., VANRUMBEKE, M., QUESNEL, B., COSSON, A. and FENAUX, P., Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis. Leukemia, 8, 1342-1349 (1994).
15. MUKHOPADHYAY, D., TSIOKAS, L. and SUKHATME, V.P., Wild-type p53 and v-src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res., 55, 6161-6165 (1995).
16. RAK, J., MITSUHASHI, Y., BAYKO, L., FILMUS, J., SHIRASAWA, S., SASAZUKI, T. and KERBEL, R.S., Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res., 55, 4575-4580 (1995).
17. SCHNEIDER, J., RUBIO, M.P., RODRIGUEZ-ESCUDERO, F.J., SEIZINGER, B.R. and CASTRESANA, J.S., Idenfication of p53 mutations by means of single strand comparison with polymorphism analysis in gynaecological tumors comparison with the results of immunohistochemistry. Europ. J. Cancer, 30, 504-508 (1994).
18. SJÖGREN, S., INGANAS, M., NORBERG, T., LINDGREN, A., NORDGREN, H., HOLMBERG, L, and BERGH, J., The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J. nat. Cancer Inst., 88, 173-182 (1996).
19. TAKAHASHI, Y., CLEARY, K.R., MAI, M., KITADAI, Y., BUCANA, C.D. and ELLIS, L.M., Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin. Cancer Res., 2, 1679-1684 (1996).
20. TAKAHASHI, Y., KITADAI, Y., BUCANA, C.D., CLEARY, K.R. and ELLIS, L.M., Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res., 55, 3964-3968 (1995).
21. TAKAHASHI, Y., TUCKER, S.L., KITADAI, Y., KOURA, A.N., BUCANA, C.D., CLEARY, K.R. and ELLIS, L.M., Vessel counts and VEGF expression as prognostic factors in node-negative colon cancer. Arch. Surg., 132, 541-546 (1997).
22. UEBA, T., NOSAKA, T., TAKAHASHI, J.A., SHIBATA, F., FLORKIEWICZ, R.Z., VOGELSTEIN, B., ODA, Y. KIKUCHI, H. and HATANAK, U., Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells. Proc. nat Acad. Sci. (Wash.), 91, 9009-9013 (1994).
23. VERMEULEN, P.B., ROLAND, L., MERTENS, V., MARCK, E.V., DE BRUIJN, E.A., VAN OOSTEROM, A.T. and DIRIX, L. Y., Correlation of intratumoral microvessel density and p53 protein overexpression in human colorectal adenocarcinoma. Microvasc. Res., 51, 164-174 (1996).
24. WARREN, R.S., YUAN, H., MATLI, M.R., GILLETT, N.A. and FERRARA, N., Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. clin. Invest., 95, 1789-1797 (1995).
25. WEIDNER, N., SEMPLE, J.P., WELCH, W.R. and FOLKMAN, J., Tumor angiogenesis and metastasis-correlation in invasive breast cancer. N. Engl. J. Med., 324, 1-8 (1991).
26. YUKAWA, M., FUJIMORI, T., MAEDA, S., TABUCHI, M. and NAGASAKO, K., Comparative clinicopathological and immunohistochemical study of ras and p53 in flat and polypoid type colorectal tumours. Gut, 35, 1258-1261 (1994).
27. ZENG, Z.S., SARKIS, A.S., ZHANG, Z.F., KLIMSTRA, D.S., CHARYTONOWICZ, E., GUILLEM, J.G., CORDON-CARDO, C. and COHEN, A.M., p53 nuclear overexpression: an independent predictor of survival in lymph node-positive colorectal cancer patients. J. clin. Oncol., 12, 2043-2050 (1994).
28. ZHANG, Z.-F., ZHANG, Z.-S., SARKIS, A.S., KLIMSTRA, D.S., CHARYTONOWICZ, E., POLLACK, D., VENA, J., GUILLEM, J., MARSHALL, J.R., CORDONCARDO, C., COHEN, A.M. and BEGG, C.B., Family history of cancer, body weight, and p53 nuclear overexpression in Duke's C colorectal cancer. Brit. J. Cancer, 71, 888-893 (1995).